Showing 1 - 15 results of 15 for search 'Balayssac, S', query time: 0.03s
Refine Results
-
1
-
2
An Experimental Approach to Assess the Sensitivity of a Smart Concrete by Shaban Shahzad, Ahmed Toumi, Jean-Paul Balayssac, Anaclet Turatsinze
Published 2023-08-01
Article -
3
-
4
Permittivity measurement of cementitious materials and constituents with an open-ended coaxial probe: combination of experimental data, numerical modelling and a capacitive model by Vincent Guihard, Frédéric Taillade, Jean-Paul Balayssac, Barthélémy Steck, Julien Sanahuja
Published 2019-07-01
Article -
5
Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study by Julie Maraud, Sabrina Bedhomme, Bruno Pereira, Sophie Trévis, Marine Jary, David Balayssac
Published 2023-06-01
Article -
6
-
7
-
8
-
9
Benchtop low-field 1H Nuclear Magnetic Resonance for detecting falsified medicines by Assemat, G, Balayssac, S, Gerdova, A, Gilard, V, Caillet, C, Williamson, D, Malet-Martino, M
Published 2018Journal article -
10
-
11
Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and... by David Balayssac, Julie Durif, Céline Lambert, Cristelle Dalbos, Eric Chapuy, Monique Etienne, Claire Demiot, Jérôme Busserolles, Vincent Martin, Vincent Sapin
Published 2023-12-01
Article -
12
Work-related stress, associated comorbidities and stress causes in French community pharmacies: a nationwide cross-sectional study by David Balayssac, Bruno Pereira, Julie Virot, Céline Lambert, Aurore Collin, David Alapini, Jean-Marc Gagnaire, Nicolas Authier, Damien Cuny, Brigitte Vennat
Published 2017-10-01
Article -
13
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice by Sylvain Lamoine, Mélissa Cumenal, David A. Barriere, Vanessa Pereira, Mathilde Fereyrolles, Laëtitia Prival, Julie Barbier, Ludivine Boudieu, Emilie Brasset, Benjamin Bertin, Yoan Renaud, Elisabeth Miot-Noirault, Marie-Ange Civiale, David Balayssac, Youssef Aissouni, Alain Eschalier, Jérôme Busserolles
Published 2021-12-01
Article -
14
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project by David Balayssac, Jérôme Busserolles, Catherine Broto, Cristelle Dalbos, Laetitia Prival, Sylvain Lamoine, Damien Richard, Mercedes Quintana, Aurélia Herbet, Sandrine Hilairet, Yang Hu, Irena Loryan, Warren E. Glaab, Laura Micheli, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Olivier Perrault, Mohamed Slaoui
Published 2023-11-01
Article -
15
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional... by Marie Selvy, Bruno Pereira, Nicolas Kerckhove, Coralie Gonneau, Gabrielle Feydel, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouché, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Jérôme Busserolles, Sophie Trevis, Vincent Pinon, Denis Pezet, David Balayssac
Published 2020-07-01
Article